releases: https://johnjoyce.house.gov/media/press-releases/dr-joyce-statement-fda-authorization-paxlovid
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://johnjoyce.house.gov/media/press-releases/dr-joyce-statement-fda-authorization-paxlovid | Dr. Joyce Statement on FDA Authorization of PAXLOVID | 2021-12-22 | 2021 | 2021-12 | Republican | House | PA | John Joyce | J000302 | johnjoyce.house.gov | johnjoyce | https://johnjoyce.house.gov/media/press-releases | scraper | Washington, DC Congressman John Joyce, M.D. (PA-13) released the following statement following the news that the Federal Drug Administration has given emergency use authorization to Pfizer's PAXLOVID medication - an oral therapeutic to help treat the symptoms of COVID-19: "An oral therapeutic a pill or tablet that prevents severe illness or hospitalization is a game changer in our battle against COVID-19," said Dr. Joyce. "American innovation and ingenuity will lead us through the pandemic, and today's announcement marks yet another American milestone alongside President Trump's Operation Warp Speed in our efforts against the coronavirus." ### | 1 | 2026-03-30T01:40:41Z | 2026-04-06T20:37:48Z |